Skip to main content
QXL Diagnostics
PRENATAL SCREENING (11–13.6 WEEKS) · FMF SOFTWARE ALGORITHM

Double Marker Test: Timing, Normal Values and How to Read Your Risk Result

The double marker test is a first-trimester screening test done between 11 weeks and 13 weeks 6 days. It measures PAPP-A and free beta-hCG in maternal blood and combines them with the nuchal translucency measurement, maternal age and gestational age to calculate the risk of Down syndrome and trisomies 18 and 13.

2 Biomarkers + Risk Software24 HoursSerum
Medically Reviewed by Dr. Shantakumar Muruda, MD Biochemistry, NABL Lead AssessorClinically Reviewed: October 2026
NABL Accredited (MC-6849) Free Home Sample Collection Same-Day Reports on WhatsApp Doctor-Reviewed Results
Department

Prenatal Screening Diagnostics

₹1895₹284033% OFF
Parameters Covered

2 Biomarkers + Risk Software

Sample Specimen

Serum (2 mL)

Report Delivery SLA

24 Hours

Preparation & Fasting Guidelines

💡 Instructions: NT Scan Report Required

When Should You Get Tested?

11 weeks 0 days to 13 weeks 6 days pregnancy windowRoutine first-trimester antenatal screeningAdvanced maternal age (35+ years)Family history of chromosomal abnormalityEarly pre-eclampsia and placental growth risk assessment

Detailed Clinical Overview

The double marker test is a first-trimester screening test done between 11 weeks 0 days and 13 weeks 6 days. It measures PAPP-A and free beta-hCG in maternal blood and combines them with the nuchal translucency measurement from ultrasound, maternal age, weight, and gestational age to calculate the risk of Down syndrome (trisomy 21) and trisomies 18 and 13. It is a screening test, not a definitive diagnosis.

Neither marker alone is sufficient — the result comes from combining biochemical levels with the nuchal translucency measured on ultrasound, maternal weight, ethnicity, smoking status, diabetes, and twin pregnancy status. Results are expressed as a probability risk figure, such as 1 in 1,200 or 1 in 150.

The timing window is strict: marker levels and nuchal translucency are only interpretable between 11 weeks 0 days and 13 weeks 6 days, dated by crown-rump length (CRL) on ultrasound. Outside that window, the second-trimester quadruple marker test becomes the alternative.

Clinical Significance

The double marker test measures two placental proteins. PAPP-A (pregnancy-associated plasma protein A) is typically low in pregnancies affected by chromosomal abnormality, and free beta-hCG is typically high in Down syndrome and low in trisomies 18 and 13. Combined first-trimester screening detects roughly 85–90% of Down syndrome pregnancies at a false-positive rate of about 5%.

Why Get Tested at QXL Diagnostics?

Routine screening for Down syndrome and trisomies 18 and 13 in the first trimester.
Offered to all pregnant women in India regardless of age, since most Down syndrome babies are born to younger mothers.
Recommended with advanced maternal age (35+ years) or previous affected pregnancy.
PAPP-A contributes to early prediction of pre-eclampsia and fetal growth restriction.
Informs whether further testing — NIPT, CVS, or amniocentesis — should be considered.

Reference Ranges — Double Marker Test: Timing, Normal Values and How to Read Your Risk Result

NABL-validated intervals · Adults · values may vary by age & sex

NormalBorderlineAbnormalReference
Parameter / GroupRangeUnitStatus
PAPP-A (Unaffected Pregnancy)0.5 – 2.0MoMNormal
PAPP-A (Down Syndrome Pattern)Typically low in trisomy 21, 18 & 13< 0.5MoMAbnormal
Free Beta-hCG (Unaffected)0.5 – 2.0MoMNormal
Free Beta-hCG (Down Syndrome)Typically elevated in Down syndrome> 2.0MoMAbnormal
Nuchal Translucency (NT)Below 95th centile for CRL< 3.0mmNormal
Combined Risk — Screen NegativeLow risk result; routine antenatal care< 1 in 250RatioNormal
Combined Risk — BorderlineDiscuss further testing (NIPT)1:250 to 1:1000RatioBorderline
Combined Risk — Screen PositiveHigh risk result — genetic counselling & NIPT/diagnostic test recommended> 1 in 250RatioAbnormal

⚕️ Reference ranges are population-based guidelines. Results must be interpreted in clinical context by a qualified physician. Always consult your doctor before making healthcare decisions.

Frequently Asked Questions

Q: When should the double marker test be done?

A: Between 11 weeks 0 days and 13 weeks 6 days of pregnancy, dated by crown-rump length on ultrasound. This window is strict — outside it the markers cannot be interpreted, and the second-trimester quadruple marker test becomes the alternative.

Q: What does the double marker test detect?

A: It estimates the risk of Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13). It does not screen for neural tube defects, structural abnormalities, thalassaemia or single-gene disorders, and it does not replace the anomaly scan at 18 to 22 weeks.

Q: What is a normal double marker test result?

A: A low-risk or screen-negative result, usually meaning a calculated risk below 1 in 250. Individual markers are reported as multiples of the median, with 0.5 to 2.0 MoM being the usual range for both PAPP-A and free beta-hCG in an unaffected pregnancy.

Q: What does a high risk double marker result mean?

A: It means your calculated probability is above the screening threshold — not that your baby has a chromosomal abnormality. Even at a risk of 1 in 100, 99 out of 100 women with that result have a normal baby. The next step is genetic counselling and, if you choose, NIPT or a diagnostic test.

Q: Is the double marker test compulsory in India?

A: It is not compulsory, but it is offered as part of routine antenatal care and is recommended for all pregnant women, not only older mothers. The decision to have it, and what to do with the result, is entirely yours, and counselling before the test is as important as counselling after it.

Q: What does low PAPP-A mean if my risk is low?

A: A very low PAPP-A with an otherwise reassuring chromosomal risk predicts a higher chance of pre-eclampsia, fetal growth restriction and preterm birth. It is a useful early warning that leads to closer monitoring of blood pressure and fetal growth, and in some cases to low-dose aspirin, which your obstetrician will advise on.

Q: Do I need to fast for the double marker test?

A: No, fasting is not required. What the test does need is accurate information — your exact gestational age by scan, your date of birth, weight, smoking and diabetes status, and whether it is a single or twin pregnancy. The risk calculation cannot be done without these.

Q: Is the double marker test or NIPT better?

A: NIPT is considerably more accurate, detecting over 99% of Down syndrome cases with a very low false-positive rate, but it costs substantially more. The double marker test is more affordable and widely available, and adds information about pre-eclampsia risk that NIPT does not. Many women in India have the double marker first and proceed to NIPT only if it is high risk.

Q: Can the double marker test be done in twin pregnancy?

A: Yes, but interpretation is more complex, because the markers come from both placentas and cannot be attributed to an individual fetus. Risk is calculated per pregnancy and per fetus using specific twin algorithms, with the nuchal translucency measured separately for each. It cannot be done reliably in triplets or higher.

Q: What happens if I miss the double marker window?

A: If you are past 13 weeks 6 days, the quadruple marker test between 15 and 20 weeks is the alternative second-trimester screen. NIPT can be done from 10 weeks onwards with no upper limit, and the anomaly scan at 18 to 22 weeks remains an essential part of screening regardless.

Doctor-Reviewed Clinical Guide2026 Evidence Update

Personalised Pregnancy Testing in Bengaluru: A Smarter Guide to Prenatal Care

Learn which antenatal tests matter at each trimester, how Double Marker compares to NIPT, and how to plan doctor-guided screening in Bengaluru.

Read Guide
₹1895₹284033% OFF

Includes free doorstep home sample collection

Book Home Collection →Or call: +91 9964 639 639
Doctor-Reviewed Content
Dr. Shantakumar Muruda

MD Biochemistry, NABL Lead Assessor · Prenatal Screening Diagnostics

Double marker screening provides a risk ratio, not a diagnostic result. Screen-positive results (>1:250) are followed up with non-invasive prenatal testing (NIPT) or amniocentesis after detailed genetic counseling. Low PAPP-A (<0.4 MoM) independently predicts pre-eclampsia and growth restriction, guiding proactive obstetric surveillance.

Clinically reviewed · October 2026 · QXL Diagnostics NABL Lab

NABL Quality Guarantees

NABL Accredited (MC-6849)

ISO 15189:2022 quality compliance

Same-Day Digital Reports

Delivered straight to WhatsApp & Email

Free Doorstep Collection

Sterile vacuum containers & cold-chain kits

Double Marker Test: Timing, Normal Values and How to Read Your Risk Result

₹1895₹284033% OFF
Book Now →